H

Health Catalyst

Healthcare data platform with analytics

GRC Manager / Offshore Team Lead

Full-TimeUpdated on 10/20/2026
No salary listed
Senior
Bachelor's
Hyderabad, Telangana, India+1 moreMore locations: Punjab, India
In Person
CybersecuritySecurity Governance, Risk & Compliance

About the job

Requirements
  • A bachelor's degree in Cybersecurity, Information Security, Computer Science, Information Technology, Business, or a related field, or equivalent professional experience.
  • At least 5 years of experience in Governance, Risk & Compliance, Information Security, Audit, or related disciplines.
  • Demonstrated experience leading teams, projects, or operational functions within a compliance or security environment.
  • Strong understanding of HITRUST, SOC 2, ISO 27001, NIST, and related governance and compliance frameworks.
  • Strong communication skills and the ability to discuss compliance frameworks with technical and non-technical stakeholders.
  • One or more of the following certifications is required: HITRUST CCSFP, CISM, CRISC, or similar.
  • Comfort navigating ambiguity and changing priorities while maintaining focus on business objectives and deliverables.
  • Strong critical-thinking and analytical skills, including the ability to assess problems, identify root causes, and recommend practical solutions.
  • Initiative, accountability, and willingness to take ownership beyond formally assigned responsibilities when needed.
  • A demonstrated track record of closing audits and remediation efforts from findings through final sign-off.
  • Ability to take ownership of delegated work end to end and keep leadership updated at key milestones through completion.
  • Ability to build working relationships with internal and external stakeholders and use those relationships to advance objectives across teams and channels outside the role's direct control.
Responsibilities
  • Establish and scale Health Catalyst's offshore GRC function in India, including supporting the definition of team structure, operational processes, onboarding plans, and performance expectations.
  • Provide day-to-day leadership, coaching, and guidance to offshore team members while fostering accountability, quality, collaboration, and continuous improvement.
  • Track, analyze, and report key performance indicators related to customer risk assessments, evidence management, policy governance, and other GRC operational activities.
  • Review evidence submissions for accuracy, completeness, relevance, and audit readiness before use in audits, customer assessments, or compliance reporting.
  • Partner with U.S.-based GRC leadership to align priorities, communicate progress, address challenges, and ensure consistency across global operations.
  • Evaluate existing GRC processes, identify improvement opportunities, and implement solutions that enhance efficiency, consistency, scalability, and control effectiveness.
  • Actively identify opportunities to apply AI and automation to reduce manual work in evidence gathering and routine reporting, redirecting time toward higher-value risk analysis.
  • Establish and scale the offshore GRC function through onboarding, training, and development of team members.
  • Achieve greater than 95% on-time delivery of assigned customer assurance requests.
  • Ensure 100% of in-scope policies are reviewed within required review cycles.
  • Achieve less than 5% evidence rejection or resubmission due to quality, completeness, or relevance issues.
  • Identify, document, and implement at least one meaningful process improvement initiative per quarter.
  • Establish trusted working relationships with leadership, control owners, and stakeholders.
  • Proactively identify risks, process gaps, and operational challenges and develop practical solutions.
  • Contribute recommendations that improve GRC program maturity, audit readiness, scalability, and operational effectiveness.
Desired Qualifications
  • Experience with GRC platforms such as Anecdotes or similar.
  • Familiarity with policy management tools and audit processes.
  • Knowledge of cloud environments and SaaS security principles.

About the company

H

Health Catalyst

View
Website

Health Catalyst provides data and analytics solutions for the healthcare industry. Its core platform, the Data Operating System (DOS), collects and organizes clinical, financial, and operational data from hospitals to enable analytics, while AI-powered analytics apps help users derive insights. It differentiates itself by offering an integrated, healthcare-specific data platform that supports data-driven decisions across clinical and operational areas, not just standalone tools. Its goal is to help healthcare organizations improve patient outcomes and financial and operational performance through scalable data infrastructure and actionable insights.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

South Jordan, Utah

Founded

2008

Get referred to Health Catalyst

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 31, 2026 Vitalware sale retired about $160 million of debt.
  • Q2 2026 adjusted EBITDA reached $9.9 million despite revenue falling 12.7%.
  • Kohl joined September 14, 2026 after transforming Performant into a $670 million sale.

What critics are saying

  • Q3 2026 revenue guidance of $55-$56 million signaled a 27% sequential drop.
  • Management expects migration-related churn and down-selling to pressure results through 2027.
  • If Ignite migrations stall, 2027 revenue shrinks before AI replaces Vitalware.

What makes Health Catalyst unique

  • 18 years of proprietary healthcare data power $2.8 billion in validated outcomes.
  • Ignite and DOS integrate clinical, financial, and operational data for health systems.
  • Simeon Kohl's September 2026 reset sharpens focus on AI-driven healthcare intelligence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

2%
PR Newswire
Sep 14th, 2026
Health Catalyst appoints Tami Reller to board as AI-forward firm touts $2.8B in validated outcomes

Health Catalyst has appointed Tami Reller to its board of directors, effective 1 October 2026. Reller will serve as audit chair and as a member of the compensation committee. The appointment follows the naming of Simeon Kohl as chief executive officer and president, effective 14 September 2026. Under Kohl's leadership, Health Catalyst will position itself as an AI-forward healthcare intelligence company built on 18 years of results and $2.8 billion in validated outcomes. Reller previously served in various leadership roles at Duly Health and Care, including as chief executive officer from 2022 to 2023. She has also held senior positions at Microsoft and multiple leadership roles at UnitedHealth Group subsidiaries. Reller brings extensive public company board experience, having served on the boards of SPS Commerce since 2016 and Avalara until its acquisition in 2022.

City Colleges of Chicago
Sep 9th, 2026
City Colleges of Chicago outlines vision to drive economic mobility and prosperity across Chicago.

City Colleges of Chicago outlines vision to drive economic mobility and prosperity across Chicago. September 9, 2026 By City Colleges of Chicago At a City Club of Chicago luncheon attended by civic, business, philanthropic, education, and government leaders, Chancellor Juan Salgado highlighted City Colleges of Chicago's growing role as the city's most accessible engine of economic opportunity and outlined a bold vision for the institution's future. Speaking to a packed audience, Salgado emphasized that Chicago's long-term success depends on ensuring that every resident can access high-quality educational pathways and participate in the opportunities created by the city's growing economy. He framed City Colleges' work around a central goal: advancing students' upward mobility and catalyzing lasting financial prosperity for students, their families, and Chicago. As industries such as healthcare, advanced manufacturing, artificial intelligence, engineering, and quantum technology expand across Illinois, City Colleges is positioning students to fill in-demand jobs while helping employers address critical workforce needs. City Colleges serves 74,000 students annually and contributes an estimated $3.5 billion in income to the regional economy each year. Chancellor Salgado highlighted significant progress achieved over the past several years, including strong enrollment gains among Black and Latine students, record growth in degrees and certificates awarded, and improvements in student success outcomes. He reaffirmed City Colleges' ambitious "55 for All" goal, which seeks to ensure that 55 percent of students across all racial groups earn a degree, credential, or transfer within four years by 2032. The Chancellor also underscored the importance of partnerships in driving student success. Through the Chicago Roadmap, City Colleges and Chicago Public Schools have expanded opportunities for students to earn college credit while still in high school, increasing participation in Early College programs and creating clearer pathways to college and careers. City Colleges has grown that model through partnerships with four-year universities, including the University of Illinois Chicago and Chicago State University, to create seamless transfer pathways that accelerate bachelor's degree attainment. Recognizing the challenges many students face outside the classroom, Chancellor Salgado highlighted investments in wraparound supports, including mental health services, food security initiatives, mentoring programs, and emerging strategies to address housing insecurity. These efforts are designed to help students persist and thrive while balancing work, family, and educational responsibilities. The speech showcased innovative workforce partnerships that are aligning education more closely with employer demand. Among them is HealthCatalyst, a collaboration with Cook County Health that will prepare and employ hundreds of healthcare workers annually through hands-on training and apprenticeships. Chancellor Salgado also highlighted the institution's growing engineering and technology programs, partnerships with employers such as DMG MORI and Amazon Web Services, and the launch of the Chicago Moonshot initiative, an ambitious apprenticeship model expected to connect hundreds of students each year to paid career opportunities. Innovative partnerships and unparalleled student supports have been launched through unprecedented increases in fundraising - tripling private and public funds raised since 2017, with $22M raised last year through the City Colleges of Chicago Foundation. Throughout the address, Chancellor Salgado shared stories of students and alumni whose lives have been transformed through City Colleges, demonstrating the institution's ability to create pathways to good-paying careers, homeownership, entrepreneurship, and long-term financial stability. He concluded with a call to action, urging employers, universities, philanthropy, government, and civic leaders to continue working together to ensure that Chicago's economic growth is broadly shared. "The future of Chicago will be determined by whether Chicagoans can participate in the opportunities our economy creates," Salgado said. "When innovation and inclusion move together, we create not only economic growth, but true economic prosperity." Veronica Resa, City Colleges of Chicago (e) [email protected] 30 total views

GlobeNewswire
Sep 8th, 2026
Health Catalyst appoints Simeon Kohl as Chief Executive Officer and President.

Health Catalyst appoints Simeon Kohl as Chief Executive Officer and President. Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business Officer. SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) - Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company's Board of Directors, effective September 14, 2026. Simeon Kohl most recently served as Chief Executive Officer of Performant Healthcare, a public healthcare company he led through a period of significant strategic and operational transformation, culminating in its successful sale to Machinify for approximately $670 million. He brings more than 20 years in healthcare, spanning operations, growth, and public-company leadership. The Company's current CEO and President, Ben Albert, will become Chief Business Officer and will step down from the Board of Directors effective September 13, 2026. "We're pleased to welcome Simeon Kohl to Health Catalyst," said Justin Spencer, Chairman of the Board. "Simeon is a seasoned public-company healthcare leader with a strong track record of driving operational performance and creating shareholder value. The Board knows Simeon and his record well and engaged with him extensively in consideration for this role. We believe his experience, operating discipline, and leadership approach are particularly well suited to Health Catalyst and the opportunities ahead. We're also deeply grateful to Ben for the important work he has led and are pleased that he will continue as a key member of the leadership team." Following the progress made under his leadership, Ben Albert concluded that this was the right time to transition the CEO role as Health Catalyst moves into its next phase. He will continue playing an important role in the Company's future as Chief Business Officer, working closely with Kohl and the leadership team to advance Health Catalyst's strategic priorities. During his tenure, Ben Albert led the Company's strategic priorities and operating initiatives and aligned the leadership team now running the business. He sharpened the Company's focus on its highest-conviction technologies, positioning Health Catalyst as an AI-forward healthcare intelligence company built to solve some of healthcare's hardest problems. To support that focus, he led the divestiture of Vitalware, which enabled the Company to retire its approximately $160 million credit facility and strengthen its balance sheet. "I care deeply about Health Catalyst and this team, and I'm proud of what we have accomplished together," said Ben Albert. "This was a thoughtful decision about what is best for the Company and me. I have confidence in Simeon and believe he is the right leader for what comes next." Simeon Kohl said, "I was drawn to Health Catalyst because it brings together two things I care deeply about: improving healthcare and building high-performing organizations. The company has an important mission, exceptionally talented people, and nearly two decades of proprietary data behind $2.8 billion in documented outcomes. The opportunity to build on those strengths to drive stronger growth and operating performance is what made this role so compelling to me." About Health Catalyst Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action. Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding the impact of Kohl's appointment to President, CEO and a member of the Board, Albert's transition to Chief Business Officer, and future performance and opportunities of Health Catalyst. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market or industry conditions, regulatory environment, and receptivity to our technology and services; (iii) results of litigation or a security incident; (iv) the loss of one or more key clients or partners, clients reducing or eliminating their spend with us, client churn or down-selling in connection with the migration to Ignite or otherwise; (v) fluctuations in our project-based, non-recurring revenue, (vi) macroeconomic challenges (including high inflationary and/or high interest rate environments, tariffs, or market volatility and measures taken in response thereto), natural disasters or any new public health crises, and regional or global conflicts (including in the Middle East); (vii) the divestiture of Vitalware may not achieve some or all of the expected benefits and may adversely affect our business; and (viii) changes to our abilities to recruit and retain qualified team members. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our reports filed with the Securities Exchange Commission (SEC), including, but not limited to the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, filed with the SEC on August 6, 2026, and the Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 12, 2026. All information provided in this release and in the attachments is as of the date hereof, and we undertake no duty to update or revise this information unless required by law. Health Catalyst Investor Relations Contact Stephanie St. Clair Finance and Investor Relations, SVP +1 (855)-309-6800 [email protected] Health Catalyst Media Contact Kay Blazar VP, PR SVM PR & Marketing [email protected]

GlobeNewswire
Aug 31st, 2026
Health Catalyst to participate in upcoming Investor Conference.

Health Catalyst to participate in upcoming Investor Conference. SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) - Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026. About Health Catalyst Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action. Health Catalyst Investor Relations Contact: Stephanie St. Clair Finance and Investor Relations, SVP +1 (855)-309-6800 [email protected] Health Catalyst Media Contact Kay Blazar VP, PR SVM PR & Marketing [email protected]

Yahoo Finance
Aug 15th, 2026
Health Catalyst Q2 revenue falls 12.7% to $70.5M after divestiture, slashes full-year guidance

Health Catalyst reported second-quarter revenue of $70.49 million, beating analyst estimates of $69.05 million despite a 12.7% year-on-year decline. The healthcare data analytics company attributed the drop primarily to client migrations and reduced lower-margin services. CEO Ben Albert said the decision to divest Vitalware, its revenue cycle management business, was necessary to focus on core areas. The sale provided immediate benefits including significant debt elimination. The company lowered its full-year revenue guidance to $247.5 million at the midpoint from $262.5 million, a 5.7% decrease. EBITDA guidance of $18.25 million came in below analyst estimates of $32.09 million. Adjusted EBITDA of $9.92 million exceeded estimates of $9.43 million, representing a 14.1% margin. Operating margin was negative 51.8%, down from negative 46% in the same quarter last year.